Regulation of Both Glycogen Synthase and PHAS-I by Insulin in Rat Skeletal Muscle Involves Mitogen-activated Protein Kinase-independent and Rapamycin-sensitive Pathways

Abstract

Incubating rat diaphragm muscles with insulin increased the glycogen synthase activity ratio (minus glucose 6-phosphate/plus glucose 6-phosphate) by approximately 2-fold. Insulin increased the activities of mitogen-activated protein (MAP) kinase and the M r ‫؍‬ 90,000 isoform of ribosomal protein S6 kinase (Rsk) by approximately 1.5-2.0-fold. Epidermal growth factor (EGF) was more effective than insulin in increasing MAP kinase and Rsk activity, but in contrast to insulin, EGF did not affect glycogen synthase activity. The activation of both MAP kinase and Rsk by insulin was abolished by incubating muscles with the MAP kinase kinase (MEK) inhibitor, PD 098059; however, the MEK inhibitor did not significantly reduce the effect of insulin on activating glycogen synthase. Incubating muscles with concentrations of rapamycin that inhibited activation of p70 S6K abolished the activation of glycogen synthase. Insulin also increased the phosphorylation of PHAS-I (phosphorylated heat-and acid-stable protein) and promoted the dissociation of the PHAS-I⅐eIF-4E complex. Increasing MAP kinase activity with EGF did not mimic the effect of insulin on PHAS-I phosphorylation, and the effect of insulin on increasing MAP kinase could be abolished with the MEK inhibitor without decreasing the effect of insulin on PHAS-I. The effects of insulin on PHAS-I were attenuated by rapamycin. Thus, activation of the MAP kinase/Rsk signaling pathway appears to be neither necessary nor sufficient for insulin action on glycogen synthase and PHAS-I in rat skeletal muscle. The results indicate that the effects of insulin on increasing the synthesis of glycogen and protein in skeletal muscle, two of the most important actions of the hormone, involve a rapamycin-sensitive mechanism that may include elements of the p70 S6K signaling pathway.

Differential Signaling of Insulin and IGF-1 Receptors to Glycogen Synthesis in Murine Hepatocytes

“…It appears, however, that this mechanism is not the only one by which insulin regulates glycogen synthesis. On the basis of studies with the inhibitor rapamycin, it appears that p70 S6 kinase is also involved in this process in 3T3-L1 adipocytes (26) and in muscle (27), but not in hepatocytes (11). Furthermore, it has been proposed that insulin activates one or more glycogen synthase phosphatases, even though the exact sequence of mediators in this process remains controversial.…”

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy

“…Actually, mTORC1-related signals seem to prefer to affect the translation of oncogenic proteins involved in protein synthesis, invasion and metastasis [49]. Moreover, mTORC1 also regulates some other proteins such as hypoxia-inducible factor 1α (HIF-1α), protein phosphatase 2A (PP2A), glycogen synthase, and signal transducer and activator of transcription (STAT) 3, through which mTORC1 promotes biosynthesis of proteins, lipids and nucleotides in aberrant cells, tissue and organism growth in cancer [2,50,51,52,53,54].…”

mTOR Cross-Talk in Cancer and Potential for Combination Therapy

“…Furthermore, mTORC1 is also involved in the regulation of other proteins including Ornithine DeCarboxylase (ODC), glycogen synthase, Hypoxia-Inducible Factor 1α (HIF-1 α), lipin, Protein Phosphatase 2A (PP2A) and Signal Transducer and Activator of Transcription (STAT) 3 [ 43 , 44 , 45 , 46 , 47 , 48 , 49 ]. Through the regulation of these protein sets, mTORC1 promotes the biosynthesis of macromolecules, as well as proteins, lipids, and nucleotides to build the biomass underlying cell, tissue, and organism growth [ 2 ].…”